- Home
- BDRX vs VERO Comparison
BDRX vs VERO Comparison
Compare BDRX & VERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDRX
- VERO
- Stock Information
- Founded
- BDRX 2000
- VERO N/A
- Country
- BDRX United Kingdom
- VERO Canada
- Employees
- BDRX N/A
- VERO N/A
- Industry
- BDRX Biotechnology: Pharmaceutical Preparations
- VERO Medical/Dental Instruments
- Sector
- BDRX Health Care
- VERO Health Care
- Exchange
- BDRX Nasdaq
- VERO Nasdaq
- Market Cap
- BDRX 2.4M
- VERO 2.2M
- IPO Year
- BDRX N/A
- VERO N/A
- Fundamental
- Price
- BDRX $3.93
- VERO $0.31
- Analyst Decision
- BDRX Strong Buy
- VERO
- Analyst Count
- BDRX 1
- VERO 0
- Target Price
- BDRX $200.00
- VERO N/A
- AVG Volume (30 Days)
- BDRX 381.2K
- VERO 418.6K
- Earning Date
- BDRX 12-27-2024
- VERO 11-13-2024
- Dividend Yield
- BDRX N/A
- VERO N/A
- EPS Growth
- BDRX N/A
- VERO N/A
- EPS
- BDRX N/A
- VERO N/A
- Revenue
- BDRX $104,895.00
- VERO $67,200,000.00
- Revenue This Year
- BDRX N/A
- VERO N/A
- Revenue Next Year
- BDRX N/A
- VERO $4.39
- P/E Ratio
- BDRX N/A
- VERO N/A
- Revenue Growth
- BDRX N/A
- VERO N/A
- 52 Week Low
- BDRX $3.50
- VERO $0.28
- 52 Week High
- BDRX $74.00
- VERO $2.22
- Technical
- Relative Strength Index (RSI)
- BDRX 36.40
- VERO 41.44
- Support Level
- BDRX $4.14
- VERO $0.30
- Resistance Level
- BDRX $4.39
- VERO $0.38
- Average True Range (ATR)
- BDRX 0.57
- VERO 0.03
- MACD
- BDRX -0.06
- VERO 0.00
- Stochastic Oscillator
- BDRX 3.34
- VERO 13.33
About BDRX Biodexa Pharmaceuticals plc American Depositary Shs
Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.
About VERO Venus Concept Inc.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.